Triage Considerations for Patients Referred for Structural Heart Disease Intervention During the COVID-19 Pandemic: An ACC/SCAI Position Statement
- PMID: 32250751
- PMCID: PMC7270905
- DOI: 10.1016/j.jcin.2020.04.001
Triage Considerations for Patients Referred for Structural Heart Disease Intervention During the COVID-19 Pandemic: An ACC/SCAI Position Statement
Abstract
The coronavirus disease-2019 (COVID-19) pandemic has strained health care resources around the world, causing many institutions to curtail or stop elective procedures. This has resulted in an inability to care for patients with valvular and structural heart disease in a timely fashion, potentially placing these patients at increased risk for adverse cardiovascular complications, including CHF and death. The effective triage of these patients has become challenging in the current environment as clinicians have had to weigh the risk of bringing susceptible patients into the hospital environment during the COVID-19 pandemic against the risk of delaying a needed procedure. In this document, the authors suggest guidelines for how to triage patients in need of structural heart disease interventions and provide a framework for how to decide when it may be appropriate to proceed with intervention despite the ongoing pandemic. In particular, the authors address the triage of patients in need of transcatheter aortic valve replacement and percutaneous mitral valve repair. The authors also address procedural issues and considerations for the function of structural heart disease teams during the COVID-19 pandemic.
Keywords: COVID-19; MitraClip; TAVR; structural heart disease.
Copyright © 2020 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
Comment in
-
TAVR During the COVID-19 Pandemic: The ACC/SCAI Consensus Statement.JACC Cardiovasc Interv. 2020 Jul 13;13(13):1605-1606. doi: 10.1016/j.jcin.2020.04.053. Epub 2020 May 3. JACC Cardiovasc Interv. 2020. PMID: 32646703 Free PMC article. No abstract available.
-
Performing Structural Heart Disease Interventions During the COVID-19 Pandemic: But What Are the Downsides?JACC Cardiovasc Interv. 2020 Jul 13;13(13):1606-1607. doi: 10.1016/j.jcin.2020.05.007. Epub 2020 May 12. JACC Cardiovasc Interv. 2020. PMID: 32646704 Free PMC article. No abstract available.
References
-
- Centers for Medicare and Medicaid Services Non-emergent, elective medical services, and treatment recommendations. https://www.cms.gov/files/document/31820-cms-adult-elective-surgery-and-... Available at:
-
- Elbaz-Greener G., Maish S., Fang J. Temporal trends and clinical consequences of wait times for transcatheter aortic valve replacement: a population study. Circulation. 2018;138:483–493. - PubMed
-
- Hyman M.C., Vemulapalli S., Szeto W.Y. Conscious sedation versus general anesthesia for transcatheter aortic valve replacement: insights from the national ACC/STS TVT Registry. Circulation. 2017;136:2132–2140. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical